Evan Rothstein, Craig Hemenway, Paul Prendergast and Cara Crowley-Weber, shareholders in Brownstein Hyatt Farber Schreck’s Denver office, are named in this year’s 2017 Intellectual Asset Magazine (IAM) Patent 1000 rankings.
Evan Rothstein, chair of the firm’s Intellectual Property Department, is recognized in the guide’s litigation category. Hemenway, Prendergast and Crowley-Weber are again recognized by IAM for their work in patent prosecution and intellectual property transactions.
Every year, IAM compiles a list of the top 1,000 patent attorneys in the world and breaks it down by country and U.S. state, recommending those considered leaders in the field. The process involves extensive international research including interviews with more than 1,500 individuals to gather feedback from peers and clients with knowledge of the attorneys’ practices and markets.
Brownstein’s full-service Intellectual Property Department assists clients in a wide variety of complex issues including patent, trademark, trade secret and copyright prosecution; counseling and protection; M&A due diligence and valuation; and data monetization, privacy, and technology consulting. In just four years, the practice has grown from five to nearly 40 practitioners who help clients realize the full value of intellectual property rights through acquisitions, licensing agreements, joint ventures and development strategies, and guide clients through product development as well as any issue associated with the acquisition, enforcement and exploitation of intellectual property.
The IAM Patent 1000 Guide notes “this ‘politically astute and connected firm’ is ‘really thoughtful in the way it grows and moves into new areas,’ and is ‘an up-and-coming name’ which is ‘making serious inroads with leading technology companies.’ What started out not too long ago as a prosecution and licensing practice has since evolved into an all-round patent service which also includes litigation; by listing members of the group in all tables, the IAM Patent 1000 underscores its impressive versatility.”
Rothstein leads the firm’s Intellectual Property practice and counsels clients looking for creative solutions to complex disputes in patent litigation and innovative strategies for managing and growing their intangible assets. Working with clients throughout the country, Rothstein handles challenging patent, trademark, copyright and trade secret matters, including taking complex cases through trial where he has significant first-chair experience. He often relies on this expertise to overhaul clients’ intellectual property assets through analytical audits and studies.
Hemenway, Brownstein’s lead patent attorney for high-tech matters, has been recognized by IAM each year since 2014 for both prosecution and transactions. He works with both startups and major corporations, including a Fortune 50 technology client, providing strategic counseling, managing complex portfolios of patent assets, advising on complex IP transactions, licensing IP assets, and providing opinions of counsel. He is a former control systems engineer with deep experience in both patent law and engineering.
Prendergast has ranked since 2014, and is a patent attorney focusing on life science and chemical issues in the areas of patent prosecution, strategic patent portfolio advice, reexaminations, clearance counseling, diligence analysis, opinion counsel and post-grant proceedings. His experience spans various aspects of intellectual property law, including U.S. and foreign patent prosecution, freedom to operate opinions, infringement and validity opinions, licensing agreements, and overall due diligence reviews.
Crowley-Weber has ranked since 2015. Her practice is a combination of opinion practice, due diligence and patent prosecution in the biotechnology, chemical, energy and agriculture industries. Her work includes advising clients on intellectual property matters related to freedom-to-operate opinions, non-infringement and invalidity opinions, due diligence assessments for mergers and acquisitions or investments, licensing agreements, and U.S. and foreign patent prosecution.